162 related articles for article (PubMed ID: 26775260)
21. Gram-scale synthesis of pinusolide and evaluation of its antileukemic potential.
Shults EE; Velder J; Schmalz HG; Chernov SV; Rubalova TV; Gatilov YV; Henze G; Tolstikov GA; Prokop A
Bioorg Med Chem Lett; 2006 Aug; 16(16):4228-32. PubMed ID: 16781150
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoid receptor-mediated regulation of intracellular calcium by delta(9)-tetrahydrocannabinol in resting T cells.
Rao GK; Zhang W; Kaminski NE
J Leukoc Biol; 2004 May; 75(5):884-92. PubMed ID: 14966196
[TBL] [Abstract][Full Text] [Related]
23. Apoptosis induction in peripheral leukemia cells by remission induction treatment in vivo: selective depletion and apoptosis in a CD34+ subpopulation of leukemia cells.
Stahnke K; Eckhoff S; Mohr A; Meyer LH; Debatin KM
Leukemia; 2003 Nov; 17(11):2130-9. PubMed ID: 14523471
[TBL] [Abstract][Full Text] [Related]
24. In vitro cytotoxicity of docetaxel in childhood acute leukemias.
Consolini R; Pui CH; Behm FG; Raimondi SC; Campana D
J Clin Oncol; 1998 Mar; 16(3):907-13. PubMed ID: 9508172
[TBL] [Abstract][Full Text] [Related]
25. Gamma-secretase inhibitors suppress the growth of leukemia and lymphoma cells.
Kogoshi H; Sato T; Koyama T; Nara N; Tohda S
Oncol Rep; 2007 Jul; 18(1):77-80. PubMed ID: 17549349
[TBL] [Abstract][Full Text] [Related]
26. The anti-cancer drug, phenoxodiol, kills primary myeloid and lymphoid leukemic blasts and rapidly proliferating T cells.
Herst PM; Davis JE; Neeson P; Berridge MV; Ritchie DS
Haematologica; 2009 Jul; 94(7):928-34. PubMed ID: 19535345
[TBL] [Abstract][Full Text] [Related]
27. Essential role for cyclic-AMP responsive element binding protein 1 (CREB) in the survival of acute lymphoblastic leukemia.
van der Sligte NE; Kampen KR; ter Elst A; Scherpen FJ; Meeuwsen-de Boer TG; Guryev V; van Leeuwen FN; Kornblau SM; de Bont ES
Oncotarget; 2015 Jun; 6(17):14970-81. PubMed ID: 26008971
[TBL] [Abstract][Full Text] [Related]
28. MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment?
Muntean AG; Hess JL
Cancer Cell; 2008 Jun; 13(6):465-7. PubMed ID: 18538728
[TBL] [Abstract][Full Text] [Related]
29. Focal adhesion kinase as a target in the treatment of hematological malignancies.
Yin B
Leuk Res; 2011 Oct; 35(10):1416-8. PubMed ID: 21592572
[TBL] [Abstract][Full Text] [Related]
30. One-pot heterogeneous synthesis of Δ(3)-tetrahydrocannabinol analogues and xanthenes showing differential binding to CB(1) and CB(2) receptors.
Rosati O; Messina F; Pelosi A; Curini M; Petrucci V; Gertsch J; Chicca A
Eur J Med Chem; 2014 Oct; 85():77-86. PubMed ID: 25072877
[TBL] [Abstract][Full Text] [Related]
31. A novel thiosemicarbazone as a promising effective and selective compound for acute leukemia.
Perondi DM; Jacques AV; Stefanes NM; Maioral MF; Sens L; Pacheco LA; Cury NM; Nunes RJ; Yunes JA; Santos-Silva MC
Anticancer Drugs; 2019 Sep; 30(8):828-837. PubMed ID: 30932944
[TBL] [Abstract][Full Text] [Related]
32. Flow cytometric chemosensitivity assay using JC‑1, a sensor of mitochondrial transmembrane potential, in acute leukemia.
Yokosuka T; Goto H; Fujii H; Naruto T; Takeuchi M; Tanoshima R; Kato H; Yanagimachi M; Kajiwara R; Yokota S
Cancer Chemother Pharmacol; 2013 Dec; 72(6):1335-42. PubMed ID: 24121478
[TBL] [Abstract][Full Text] [Related]
33. Pharmacogenomics of acute leukemia.
Ansari M; Krajinovic M
Pharmacogenomics; 2007 Jul; 8(7):817-34. PubMed ID: 18240908
[TBL] [Abstract][Full Text] [Related]
34. Selective Toxicity of Investigational Ixazomib for Human Leukemia Cells Expressing Mutant Cytoplasmic NPM1: Role of Reactive Oxygen Species.
Garcia JS; Huang M; Medeiros BC; Mitchell BS
Clin Cancer Res; 2016 Apr; 22(8):1978-88. PubMed ID: 26634271
[TBL] [Abstract][Full Text] [Related]
35. [Acute hybrid leukemia. Review of the literature and presentation of a case].
Guzzini F; Angelopoulos N; Banfi L; Coppetti D; Ceppi M; Camerone G
G Clin Med; 1990 Mar; 71(3):195-201. PubMed ID: 2194879
[TBL] [Abstract][Full Text] [Related]
36. Δ⁹-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells.
Sido JM; Nagarkatti PS; Nagarkatti M
J Leukoc Biol; 2015 Sep; 98(3):435-47. PubMed ID: 26034207
[TBL] [Abstract][Full Text] [Related]
37. Differential role of cannabinoids in the pathogenesis of skin cancer.
Glodde N; Jakobs M; Bald T; Tüting T; Gaffal E
Life Sci; 2015 Oct; 138():35-40. PubMed ID: 25921771
[TBL] [Abstract][Full Text] [Related]
38. Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.
Shi F; Len Y; Gong Y; Shi R; Yang X; Naren D; Yan T
PLoS One; 2015; 10(8):e0136746. PubMed ID: 26317515
[TBL] [Abstract][Full Text] [Related]
39. Apoptosis and proliferation differences between CD34+ and CD34- leukemic subpopulations in childhood acute leukemia.
Shman TV; Savitski VP; Fedasenka UU; Aleinikova OV
Hematology; 2007 Oct; 12(5):403-7. PubMed ID: 17852445
[TBL] [Abstract][Full Text] [Related]
40. Differential chemosensitivity of leukemic cells in the myeloid and lymphoid phases of stem cell leukemia (a case report).
Mihál V; Hajdúch M; Dusek J; Jarosová M; Weigl E; Pikalová Z; Indrák K; Safárová M; Janostáková A
Neoplasma; 1997; 44(2):133-6. PubMed ID: 9201294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]